Colorectal cancer screening: The surgery rates they are a-changing. A nationwide study on surgical resections in Italy.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 07 2018
revised: 21 09 2018
accepted: 17 10 2018
pubmed: 20 11 2018
medline: 14 6 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

Growing evidence suggests that colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) reduces CRC incidence and surgical resection rates. To compare trends in surgery for proximal and distal CRC among Italian regions at different stages of screening implementation. From the National Hospital Discharge Database we selected hospitalizations with CRC resection of residents aged 50-74 years during 2002-2014, and computed surgery rates for the 8 most populous Italian regions with/without a screening program. In regions with screening, implemented around 2006-2007, the annual percent change (APC) of distal CRC resection was +1.7 (95% confidence interval -1.0, 4.4) during 2002-2007 and -9.1 (-10.6, -7.7) during 2007-2014. No significant change was observed in regions without screening. The APC for proximal colon resection in regions with screening was +5.8 (2.5, 9.0) during 2002-2007 and -4.1 (-5.8, -2.4) during 2007-2014, while in regions without screening surgical rates increased through the whole study period. Compared to 2002, in 2014 distal CRC resection rates were greatly reduced in regions with screening, reaching values similar to proximal CRC resection. Following the implementation of screening programs surgery rates steeply decreased, confirming the deep impact of FIT-based screening on the burden of CRC.

Sections du résumé

BACKGROUND
Growing evidence suggests that colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) reduces CRC incidence and surgical resection rates.
AIMS
To compare trends in surgery for proximal and distal CRC among Italian regions at different stages of screening implementation.
METHODS
From the National Hospital Discharge Database we selected hospitalizations with CRC resection of residents aged 50-74 years during 2002-2014, and computed surgery rates for the 8 most populous Italian regions with/without a screening program.
RESULTS
In regions with screening, implemented around 2006-2007, the annual percent change (APC) of distal CRC resection was +1.7 (95% confidence interval -1.0, 4.4) during 2002-2007 and -9.1 (-10.6, -7.7) during 2007-2014. No significant change was observed in regions without screening. The APC for proximal colon resection in regions with screening was +5.8 (2.5, 9.0) during 2002-2007 and -4.1 (-5.8, -2.4) during 2007-2014, while in regions without screening surgical rates increased through the whole study period. Compared to 2002, in 2014 distal CRC resection rates were greatly reduced in regions with screening, reaching values similar to proximal CRC resection.
CONCLUSION
Following the implementation of screening programs surgery rates steeply decreased, confirming the deep impact of FIT-based screening on the burden of CRC.

Identifiants

pubmed: 30449608
pii: S1590-8658(18)31205-2
doi: 10.1016/j.dld.2018.10.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

304-309

Informations de copyright

Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Auteurs

Manuel Zorzi (M)

Veneto Tumour Registry, Azienda Zero, Padua, Italy. Electronic address: manuel.zorzi@azero.veneto.it.

Nicola Gennaro (N)

Regional Epidemiology Service, Azienda Zero, Padua, Italy.

Giulia Capodaglio (G)

Regional Epidemiology Service, Azienda Zero, Padua, Italy.

Emanuele Damiano Luca Urso (EDL)

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.

Salvatore Pucciarelli (S)

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.

Laura Memo (L)

Veneto Tumour Registry, Azienda Zero, Padua, Italy.

Eva Carpin (E)

Veneto Tumour Registry, Azienda Zero, Padua, Italy.

Mariachiara Corti (M)

Regional Epidemiology Service, Azienda Zero, Padua, Italy.

Massimo Rugge (M)

Veneto Tumour Registry, Azienda Zero, Padua, Italy.

Ugo Fedeli (U)

Regional Epidemiology Service, Azienda Zero, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH